By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The global Sentinel Node Biopsy market has several drivers, including the continuous advancements in medical technology and the increasing prevalence of cancer worldwide.
The increasing awareness among healthcare professionals and patients contributed to the growth of Sentinel Node Biopsy. However, the market also faces significant challenges, including technical challenges, false negative results, the cost of sentinel node biopsy, equipment, imaging agents, and surgical procedures.
The global sentinel node biopsy market offers significant growth opportunities, including growing awareness about cancer and the importance of early detection & development of innovative technologies and techniques led to the expansion of sentinel node biopsy procedures.
Sentinel node biopsy, a minimally invasive surgical treatment that has various benefits over conventional lymph node dissection, has been gradually expanding the global market in recent years.
Minimally invasive treatments are becoming more and more popular since they take less time to recover from, require shorter hospital stays, and provide patients more comfort. As a result of this change, Sentinel Node Biopsy has become the primary method for evaluating lymph nodes. The market is distinguished by a vast variety of tools, styles, and dimensions that appeal to various consumer tastes.
The continuous advancements in medical technology and the increasing prevalence of cancer worldwide are the major drivers of the market. At the same time, the limited access to advanced healthcare facilities and lack of skilled professionals are the main restraints.
The growing awareness about cancer and the importance of early detection & development of innovative technologies and techniques are the major opportunities in the market.
A sentinel node biopsy is a surgical procedure used to determine if cancer has spread beyond the primary tumor site. The sentinel node is the first lymph node to which cancer cells are likely to spread.
It is a process in which the sentinel lymph node is discovered, excised, and analyzed to see if cancer cells are present. It is used in those who have already been diagnosed with cancer.
Sentinel lymph nodes are an important aspect of the immune system because they contain cells that detect foreign things such as bacteria, viruses, and cancer. Sentinel lymph node mapping aids in identifying lymph nodes that are most likely to carry malignancy.
Breast cancer cells are more likely to travel first to lymph nodes near the damaged breast, which are located in the axilla, or armpit area. However, in breast cancers near the centre of the chest (near the breastbone), cancer cells may first spread to lymph nodes inside the chest (under the breastbone, referred to as internal mammary nodes) before being detected in the axilla.
Sentinel node biopsy is a relatively safe operation. However, as with any surgery, there is a risk of complications, which include: Bleeding. Bruising or pain at the location of the biopsy.
During a sentinel node biopsy, the surgeon removes the sentinel node and tests it for cancer cells. If cancer cells are found in the sentinel node, it is likely that the cancer has spread to other lymph nodes. Sentinel node biopsy can be used to stage breast cancer, melanoma, and other types of cancer.
The sentinel node is the first node to receive metastatic deposits in a malignancy. Lymphoscintigraphy is an important procedure because if the sentinel node is free of metastasis, subsequent nodes are also likely to be free of disease.
In most cases, a negative sentinel lymph node biopsy means the cancer has not spread. A positive biopsy means cancer was found in the lymph node. It could be in other lymph nodes and even other organs.
The Global Sentinel Node Biopsy Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Precision Medicine and Personalized SNB
Minimally Invasive and Robotic Approaches
Point-of-care Diagnostics and Rapid Results
Cost-Effectiveness and Market Access
SENTINEL NODE BIOPSY MARKET NEW PRODUCT LAUNCH
GE Healthcare’s VeriLoc Sentinel Node System
This minimally invasive system utilizes near-infrared fluorescence (NIRF) technology to locate sentinel nodes, eliminating the need for radioactive tracers and reducing patient exposure to radiation. VeriLoc offers a smaller and more comfortable injection device, minimizing pain and tissue trauma. The system’s advanced imaging capabilities provide surgeons with real-time visualization of the sentinel node, ensuring precise removal and minimizing the risk of false negatives.
Abbott’s NAVIGATE Multi-Sensor Sentinel Node System
This innovative system combines radioisotope and NIRF technologies, providing dual-modality sentinel node localization for enhanced accuracy and redundancy. NAVIGATE features a handheld probe with advanced gamma and NIRF detectors, offering greater flexibility and ease of use during surgery.The system’s integrated software provides real-time guidance and visualization, optimizing the SNB procedure for improved patient outcomes.
Medtronic’s TruNavigator Sentinel Node Localization System
This advanced system utilizes a novel “smart” gamma probe with built-in tissue impedance sensing, improving sentinel node identification in challenging cases like obese patients or those with dense lymphatic drainage.TruNavigator offers automated probe calibration and background noise reduction, ensuring reliable detection and minimizing false positives.The system’s intuitive interface and real-time feedback provide surgeons with confidence and control throughout the SNB procedure.
Philips’ BlueSentinel Lymphatic Mapping System
This innovative system utilizes a blue dye with unique optical properties, offering improved visualization and localization of lymphatic vessels during SNB. BlueSentinel is formulated for minimal tissue staining and rapid clearance, reducing patient discomfort and facilitating faster recovery. The system’s compatibility with existing surgical instruments and workflows ensures seamless integration into current surgical practices.
